CATG Microbiology & Food Safety Laboratory, Institute of Preventive Veterinary Science & Department of Veterinary Medicine, Zhejiang University College of Animal Sciences, Hangzhou, China.
Animal Health Research Division, Nepal Agricultural Research Council, Kathmandu, Nepal.
mSphere. 2020 May 27;5(3):e00163-20. doi: 10.1128/mSphere.00163-20.
serovar Newport ( Newport) infections are gradually on the rise in China from the last decade. For humans' infections, Newport has been ranked among the top five serovars responsible for persistent infections, globally. A total of 290 Newport strains with their relevant clinical metadata were analyzed, and the strains were subjected to whole-genome sequence analysis. Among these, 62.4% ( = 181) were from diarrheic patients and 28.9% ( = 84) were from asymptomatic individuals (including adults and youngsters) while 8.6% ( = 25) were from cases of persistent diarrhea in infants (28%, = 7) and toddlers (72%, = 18). The association between the sequence types (STs) and the variations in the clinical presentation was statistically significant (0.0432), with ST46 causing diarrhea or representing asymptomatic patients and ST31 or ST68 causing persistent diarrhea. Genomic analysis revealed that the highest proportion of the isolates (98.5%, = 279), primarily from patients with or without diarrhea rather than from asymptomatic individuals, carried antimicrobial resistance determinants corresponding to the aminoglycosides and beta-lactams, highlighting the need for cautionary usage of antimicrobials in such patients. These findings also suggest that cases of nontyphoidal infection with symptoms of acute diarrhea or persistent diarrhea caused by Newport should be handled with caution, due to the high chance of development of an antimicrobial resistance phenotype that might lead to therapeutic failures. Together, Newport ST31 and ST46, which have the highest frequency of carriage of multidrug resistance, are potentially responsible for antimicrobial-resistant diarrhea/persistent diarrhea in infants and children, while adult humans are more likely to be (asymptomatic) carriers of the Newport strains. Human infections caused by Newport generally lead to gastrointestinal diseases. These infections are normally self-limiting; however, in certain cases, broad-spectrum antimicrobials are prescribed for the treatment. The Chinese National Foodborne Disease Surveillance Network has reported a gradual increase in the incidence of multidrug-resistant Newport infections in humans. After careful evaluation of the dynamic relationship among the clinical findings, the age group, and the genomic sequence data, it was found that young patients represented the major group with persistent diarrhea, whereas adults were either asymptomatic or diarrheic. Furthermore, all these strains contained multiple acquired antimicrobial resistance determinants, which limited the use of antimicrobials for human patients of all age groups. This analysis of the laboratory-confirmed cases, coupled with genetic analysis of the corresponding pathogen, revealed that antimicrobial treatment of persistent infections by Newport in infants and toddlers, and in asymptomatic or diarrheic adults, may not be successful. If the antimicrobials must be prescribed at all, they must be used with caution because of the presence of multiple acquired antimicrobial resistance determinants in such strains.
纽波特血清型(Newport)感染在中国从上世纪末开始逐渐呈上升趋势。对于人类感染,纽波特已被列为全球导致持续性感染的前五大血清型之一。对总共 290 株纽波特菌株及其相关临床元数据进行了分析,并对这些菌株进行了全基因组序列分析。其中,62.4%(=181)来自腹泻患者,28.9%(=84)来自无症状个体(包括成人和青少年),8.6%(=25)来自婴儿持续性腹泻病例(28%,=7)和幼儿(72%,=18)。序列类型(ST)与临床表现变化之间的关联具有统计学意义(0.0432),ST46 引起腹泻或代表无症状患者,ST31 或 ST68 引起持续性腹泻。基因组分析显示,最高比例的分离株(98.5%,=279),主要来自腹泻患者或无症状患者,携带对应氨基糖苷类和β-内酰胺类抗生素的耐药决定因素,突出了在这些患者中谨慎使用抗生素的必要性。这些发现还表明,由纽波特引起的有症状急性腹泻或持续性腹泻的非伤寒感染病例应谨慎处理,因为可能会出现导致治疗失败的抗生素耐药表型。总的来说,携带多药耐药性的纽波特 ST31 和 ST46 频率最高,可能导致婴儿和儿童的抗生素耐药性腹泻/持续性腹泻,而成年人类更有可能成为(无症状)纽波特菌株携带者。纽波特引起的人类感染通常导致胃肠道疾病。这些感染通常是自限性的;然而,在某些情况下,会开广谱抗生素进行治疗。中国国家食源性疾病监测网络报告称,人类感染耐多药纽波特的病例逐渐增加。在仔细评估临床发现、年龄组和基因组序列数据之间的动态关系后,发现持续性腹泻的主要人群是年轻患者,而成年患者则是无症状或腹泻。此外,所有这些菌株都含有多个获得性抗生素耐药决定因素,这限制了所有年龄段人类患者对抗生素的使用。对实验室确诊病例的分析,结合相应病原体的遗传分析,表明对婴儿和幼儿以及无症状或腹泻的成年患者的纽波特持续性感染进行抗生素治疗可能不会成功。如果必须开抗生素,必须谨慎使用,因为这些菌株中存在多个获得性抗生素耐药决定因素。